Ultragenyx Pharmaceutical Inc.
$14.54
-0.63 (-4.15%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +0.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -52.2%
Own RARE?
See how RARE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.